conv.

← The whole story
Health
FDA panel votes on Grail's Galleri multi-cancer blood test

WSJ editorial board urges FDA to clear the test

1 Sep 20 4:58 PM · 3d ago · 1 article · 1 source · development 1 of 6

The Wall Street Journal's Editorial Board argues Galleri's trial data show it increases early cancer detection and accuses critics of wanting to ration care ahead of the FDA panel's review.

WSJ editorial board urges FDA to clear the test
STAT News

“The real reason some so-called experts oppose FDA approval is because it could lead to government and private insurance coverage.”

WSJ Editorial Board

Grail Inc. Maker of the Galleri multi-cancer blood testFDA Molecular and Clinical Genetics Panel Independent advisory panelVinay Prasad Former FDA biologics chiefWSJ Editorial Board Opinion commentator

The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump

Peak 7 pieces in one hour at Yesterday, 9 AM; 27 pieces over 3 days (18 articles · 9 posts) Sep 20, 4 PM — 1 piece · 1 article — Newswires 1Sep 20, 5 PM — quietSep 20, 6 PM — quietSep 20, 7 PM — quietSep 20, 8 PM — quietSep 20, 9 PM — quietSep 20, 10 PM — quietSep 20, 11 PM — quietSep 21, 12 AM — quietSep 21, 1 AM — quietSep 21, 2 AM — quietSep 21, 3 AM — quietSep 21, 4 AM — 1 piece · 1 article — Newswires 1Sep 21, 5 AM — quietSep 21, 6 AM — quietSep 21, 7 AM — quietSep 21, 8 AM — quietSep 21, 9 AM — quietSep 21, 10 AM — quietSep 21, 11 AM — quietSep 21, 12 PM — quietSep 21, 1 PM — 1 piece · 1 article — Newswires 1Sep 21, 2 PM — quietSep 21, 3 PM — quietSep 21, 4 PM — 3 pieces · 3 articles — Google News 3Sep 21, 5 PM — quietSep 21, 6 PM — quietSep 21, 7 PM — quietSep 21, 8 PM — quietSep 21, 9 PM — quietSep 21, 10 PM — quietSep 21, 11 PM — quietSep 22, 12 AM — quietSep 22, 1 AM — quietSep 22, 2 AM — quietSep 22, 3 AM — quietSep 22, 4 AM — quietSep 22, 5 AM — quietSep 22, 6 AM — quietSep 22, 7 AM — quietSep 22, 8 AM — quietSep 22, 9 AM — quietSep 22, 10 AM — quietSep 22, 11 AM — quietSep 22, 12 PM — quietSep 22, 1 PM — quietSep 22, 2 PM — quietSep 22, 3 PM — quietSep 22, 4 PM — quietSep 22, 5 PM — quietSep 22, 6 PM — quietSep 22, 7 PM — quietSep 22, 8 PM — quietSep 22, 9 PM — quietSep 22, 10 PM — quietSep 22, 11 PM — quietYesterday, 12 AM — quietYesterday, 1 AM — quietYesterday, 2 AM — quietYesterday, 3 AM — quietYesterday, 4 AM — quietYesterday, 5 AM — 3 pieces · 2 articles · 1 post — Newswires 2, Mastodon 1Yesterday, 6 AM — 3 pieces · 3 posts — Mastodon 3Yesterday, 7 AM — quietYesterday, 8 AM — 1 piece · 1 article — Newswires 1Yesterday, 9 AM — 7 pieces · 5 articles · 2 posts — Newswires 5, Mastodon 2Yesterday, 10 AM — quietYesterday, 11 AM — quietYesterday, 12 PM — quietYesterday, 1 PM — quietYesterday, 2 PM — quietYesterday, 3 PM — quietYesterday, 4 PM — 2 pieces · 1 article · 1 post — Mastodon 1, Newswires 1Yesterday, 5 PM — 1 piece · 1 article — Newswires 1Yesterday, 6 PM — 3 pieces · 2 articles · 1 post — Google News 2, Mastodon 1Yesterday, 7 PM — 1 piece · 1 post — Mastodon 1Yesterday, 8 PM — quietYesterday, 9 PM — quietYesterday, 10 PM — quietYesterday, 11 PM — quietToday, 12 AM — quiet 1234–6
1WSJ editorial board urges FDA to clear…2Grail shares surge 33% on FDA meeting…3FDA's outside expert panel meets to vote…4–6Molecular and Clinical Genetics Panel…
Sep 21Sep 22yesterdaynow · 1:00 AM ET

All 6 developments of FDA panel votes on Grail's Galleri multi-cancer blood test →

NewswiresGoogle NewsMastodon